Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Ondine Biomedical Falls as Investors Reassess the Commercialisation Path for Its Technology

Ondine Biomedical (LSE:OBI) is a classic AIM life-sciences proposition: a genuinely novel technology attacking a large clinical problem, but with the value entirely dependent on converting scientific promise into commercial revenue. The supplied headline's framing, investors reassessing the commercialisation path, is apt for a …

Ankur Sharma | 27 August 2026

Why Did Coiled Therapeutics PLC LSE:COIL Move Higher 2.94% Amid renewed investor attention on London-listed clinical-stage developers?

Coiled Therapeutics PLC — LSE:COIL rose2.94% on 27 August 2026, taking the shares to 8.75p.

Ishan Mudgal | 27 August 2026

Why Did Faron Pharmaceuticals Ltd LSE:FARN Move Higher 0.21% Amid a steadier backdrop for London-listed clinical-stage developers?

Faron Pharmaceuticals Ltd — LSE:FARN rose0.21% on 27 August 2026, taking the shares to 40.00p.

Ishan Mudgal | 27 August 2026

Fusion Antibodies LSE:FAB Stock News: OptiMAL Platform, New Patent and Biotech Growth in Focus

Fusion Antibodies PLC, traded underLSE:FAB, was among the notable decliners in the latest market snapshot for27 August 2026, with the shares down5.64%.

Ankur Sharma | 27 August 2026

Why Is ImmuPharma Stock Down 9.21%? LSE:IMM Investors Watch Lupuzor and Kapiglucagon

ImmuPharma plc (LSE:IMM) fell9.21% on 27 August 2026, extending the highly volatile trading pattern that has characterised the shares during 2026.

Ankur Sharma | 27 August 2026

Ondo InsurTech LSE:ONDO Stock News: LeakBot Growth, US Expansion and Funding Keep Shares in Focus

Ondo InsurTech PLC, traded underLSE:ONDO, was one of the notable decliners in the latest market snapshot on27 August 2026, with the shares down6.71%.

Ankur Sharma | 27 August 2026

Why Is EDX Medical Stock Down 10%? LSE:EDX Investors Watch Prostate Cancer Testing Expansion

EDX Medical Group plc (LSE:EDX) fell10.00% on 27 August 2026, placing the diagnostics specialist among the day's notable percentage decliners.

Ankur Sharma | 27 August 2026

LSE:PRTC Stock Alert: PureTech Health Gains as Deupirfenidone Enters Major Clinical Development Phase

PureTech Health plc has moved into focus on27 August 2026, withLSE:PRTC gaining 3.99%during the session.

Ankur Sharma | 27 August 2026

Shield Therapeutics Rallies as Investors Refocus on the Iron-Deficiency Treatment Story

Shield Therapeutics (LSE:STX) has spent years chasing a single, sizeable prize: turning its oral iron therapy into a commercial success in the vast US market. After a long and cash-hungry build-out, 2026 half-year results suggest the strategy is finally translating into scale, withRevenueup sharply …

Divya Sood | 27 August 2026

ImmuPharma Rallies as Biotech Speculation Sends the AIM Stock Back Into Focus

Few AIM names carry as much history — and as much accumulated hope and frustration — as ImmuPharma (LSE:IMM). The clinical-stage biotech has, for well over a decade, pursued the promise of Lupuzor, an experimental treatment for the autoimmune disease lupus. When the shares …

Ankur Sharma | 27 August 2026
Support

Hi! How can we help you today?

Loading…